| __timestamp | Genmab A/S | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 850385000 | 116287000 |
| Thursday, January 1, 2015 | 1133041000 | 136004000 |
| Friday, January 1, 2016 | 1816122000 | 203017000 |
| Sunday, January 1, 2017 | 2365436000 | 287023000 |
| Monday, January 1, 2018 | 3025137000 | 393541000 |
| Tuesday, January 1, 2019 | 5366000000 | 376095000 |
| Wednesday, January 1, 2020 | 10111000000 | 467938000 |
| Friday, January 1, 2021 | 8482000000 | 504714000 |
| Saturday, January 1, 2022 | 14595000000 | 580017000 |
| Sunday, January 1, 2023 | 16248000000 | 523742000 |
| Monday, January 1, 2024 | 20541000000 |
Unlocking the unknown
In the competitive landscape of the pharmaceutical industry, understanding financial trends is crucial. Over the past decade, Genmab A/S has demonstrated a remarkable growth trajectory in gross profit, surging by over 1,800% from 2014 to 2023. This Danish biotech powerhouse, known for its innovative cancer treatments, reached a peak gross profit of approximately $16.2 billion in 2023. In contrast, Supernus Pharmaceuticals, Inc., a U.S.-based company specializing in central nervous system disorders, experienced a more modest growth of around 350% during the same period, peaking at $580 million in 2022.
This stark contrast highlights Genmab's aggressive expansion and market penetration, while Supernus maintains steady, albeit slower, growth. Investors and industry analysts should note these trends as they reflect broader market dynamics and strategic positioning within the pharmaceutical sector.
Key Insights on Gross Profit: AbbVie Inc. vs Genmab A/S
Key Insights on Gross Profit: Regeneron Pharmaceuticals, Inc. vs Genmab A/S
Who Generates Higher Gross Profit? Alnylam Pharmaceuticals, Inc. or Supernus Pharmaceuticals, Inc.
Gross Profit Trends Compared: Genmab A/S vs Perrigo Company plc
Gross Profit Comparison: Genmab A/S and Arrowhead Pharmaceuticals, Inc. Trends
Genmab A/S and Supernus Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Gross Profit Trends Compared: Catalent, Inc. vs Supernus Pharmaceuticals, Inc.
Ascendis Pharma A/S vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Comparison: Amneal Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc. Trends
HUTCHMED (China) Limited and Supernus Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Gross Profit Comparison: Ligand Pharmaceuticals Incorporated and Supernus Pharmaceuticals, Inc. Trends
Who Generates Higher Gross Profit? Supernus Pharmaceuticals, Inc. or BioCryst Pharmaceuticals, Inc.